AI Assistance May Boost Accuracy of HER2-Low Scoring for Breast Cancers

By News Health
6 hours Ago

(MedPage Today) — CHICAGO — Artificial intelligence (AI) assistance appeared to enhance pathologists’ accuracy in identifying HER2-low or -ultralow expression in breast cancer tissue, a global study showed, which could cut down on missed opportunities…

Source link : https://www.medpagetoday.com/meetingcoverage/asco/115724

Author :

Publish date : 2025-05-22 21:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

'My son could so easily have been another Nottingham killer'

FDA Panel Recommends Monovalent COVID Vaccine for Next Season

Study Links GLP-1 Drugs to Lower Cancer Risk

FDA Chief Defends Job Cuts, COVID Booster Policy at Senate Hearing

Prasugrel Strategy Rolls Short DAPT and De-Escalation Into One

FDA Approves Roflumilast Foam for Scalp, Body Psoriasis